2014 (v1)
Publication
No description
Uploaded on: April 14, 2023
M
F
Last name: MORELLI
First name: Franco
No description
This retrospective multicenter survey analyzed modalities of dose calculation, dose reductions, acute toxicities, and relapse rate of adjuvant AUC 7 carboplatin in 115 stage I seminoma patients. The study confirms the feasibility and safety of AUC 7 carboplatin in every day clinical practice with a relapse rate of 5.2%. Dose reduction should be...
No description